fda drug shortages semaglutide injection shortage resolved 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement US judge upholds FDA's removal

GLP-1 therapy targets appetite signaling optimization, helping your body better recognize fullness and reduce overeating

3.2 New carnitine monooxygenase assay Published carnitine monooxygenase assays rely on the enzymatic quantification of the L-carnitine substrate ( Here, a simple and efficient assay was established which is based on the quantification of the second reaction product of carnitine monooxygenase (Figures 3A,B)

doi:10.2147/jpr.S395457

June 2024 Update: The latest docket report from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently 101 lawsuits filed against the manufacturers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation

Find a Prime IV location near you and schedule your appointment